Sign in
Active, not recruitingNo phase

Genomics of Sudden Cardiac Arrest

Key facts

Who runs it
University of Washington
Where
Seattle, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
14,862 people enrolled
Started
Sept 2007
Expected to end
Aug 2030
Type of study
Observational, 4 groups
Record updated
5 June 2023

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Experienced incident SCA
  • Matched to people with SCA on age, gender, and ethnicity

Who cannot take part

  • Members of a vulnerable population

Where in United States

  • Cardiovascular Health Research Unit, University of WashingtonSeattle, United States

About the trial

What the trial wants to find out

Sudden cardiac arrest (SCA) is a sudden, unexpected loss of heart function. It is a leading cause of death, and more than 400,000 people in the United States die each year as a result of SCA. This study will analyze genetic samples of people who have experienced SCA and people who have not experienced SCA to determine if there is a genetic basis for SCA.

The 4 groups in the trial

  • 1

    European American people who have experienced SCA.

  • 2

    European American people who have not experienced SCA.

  • 3

    African American people who have experienced SCA.

  • 4

    African American people who have not experienced SCA.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluating the Genetic Factors That May Lead to Sudden Cardiac Arrest (The GenSCA Study)
Record updated
5 June 2023